Adora Ndu

Director, DBV Technologies.

Companies

Acadia PharmaceuticalsBoard member Oct 14, 2022 to now¹
DBV TechnologiesBoard member Jun 1, 2021 to Feb 8, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Acadia Pharmaceuticals ACAD32,908 shares³$629.2K at $19.12May 29, 2026
DBV Technologies DBVT1,825 shares⁴$16.5K at $9.05Feb 6, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 29, 2026Exercised options 8,107 shares of Acadia Pharmaceuticals³
May 29, 2025Exercised options 9,387 shares of Acadia Pharmaceuticals⁵
Oct 12, 2024Exercised options 4,381 shares of Acadia Pharmaceuticals⁶
May 29, 2024Exercised options 6,652 shares of Acadia Pharmaceuticals⁷
Feb 6, 2024Bought 1,825 shares at $0.89 of DBV Technologies⁴
Oct 12, 2023Exercised options 4,381 shares of Acadia Pharmaceuticals⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAcadia Pharmaceuticals, Board member
2
SEC EDGARDBV Technologies, Board member
3
SEC EDGARAcadia Pharmaceuticals shares after the filing of May 29, 2026
4
SEC EDGARDBV Technologies shares after the filing of Feb 6, 2024
5
SEC EDGARForm 4 filed Jun 2, 2025
6
SEC EDGARForm 4 filed Oct 15, 2024
7
SEC EDGARForm 4 filed May 31, 2024
8
SEC EDGARForm 4 filed Oct 16, 2023